This site might not work as expected.
You're using an old browser that isn't supported by this site. Please upgrade or download one of these free and excellent browsers: https://browser-update.org/update.html

LWW Announces Partnership with American Society of Addiction Medicine

LWW will serve as publisher of ASAM's new official peer-reviewed medical journal, Journal of Addiction Medicine (JAM)

​New "Journal of Addiction Medicine" Planned for Launch in Early 2007  
 
Leading healthcare publisher Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, is pleased to announce a new publishing partnership with the American Society of Addiction Medicine (ASAM), the world's largest addiction medicine society devoted to improving the treatment of people with addiction disorders. Under this arrangement, LWW will serve as publisher of ASAM's new official peer-reviewed medical journal, Journal of Addiction Medicine (JAM). 

The premiere issue of JAM will appear in early 2007. "Under the leadership of Senior Editor George F. Koob, Ph.D., and Co-Editors Martha J. Wunsch, M.D., and Shannon C. Miller, M.D., JAM is poised to become the premiere publication in its field," says Richard Winters, Executive Editor at LWW.

"Recent years have seen major strides in our knowledge about the neurobiological causes and effects and treatment of addiction. Research has shed much light on this complex chronic health problem. As physicians, we must understand the fundamental roots of this brain-based disease and be prepared to implement promising new drug treatments. This will position us for maximal impact upon a disease that devastates lives, families, and communities," comments Dr. Wunsch. "The time has come for our specialty to have a single journal that assembles all the latest evidence for clinicians and researchers, providing us with the information to care for patients with addiction."

Each issue of Journal of Addiction Medicine will present original, peer-reviewed studies from the full range of scientific and clinical areas in Addiction Medicine research-from the neurobiology and neuropharmacology lab, to the specialty clinic, to the family doctor's office. In addition to the latest scientific and medical advances, JAM will cover the myriad ethical, economic, forensic, and social issues involved in addictive diseases.

New research will be complemented by current reviews and editorials, clinical case conferences, letters to the editors, and other content of interest to practicing physicians and all professionals who work with patients with addiction disorders. "We've assembled a wide-ranging editorial team with proven expertise reflecting the unprecedented changes happening in Addiction Medicine. This is brought to focus by the appointment of Dr. Koob as Senior Editor," says Dr. Miller. "Our goal is to provide a forum for all professionals with a stake in treating addiction disorders-a catalyst for discussions that will shape the future of our specialty."

Members of ASAM will receive each quarterly issue of JAM as a benefit of membership. Members and subscribers will also be able to access the entire contents of each issue on the dedicated journal website, online soon at  www.journaladdictionmedicine.com. The website will also provide access to LWW's Editorial Manager, an automated, web-based tool that enables users to electronically submit, review and track manuscripts and artwork online. Institutions will be able to access Journal of Addiction Medicine electronically on Journals@Ovid, which offers more than 1,200 premiere medical and academic journals, and is produced by Ovid, LWW's sister company within Wolters Kluwer Health. 

"The launch of Journal of Addiction Medicine is particularly exciting because of its translational focus," notes Dr. Koob. "Our journal will not only convey the wealth of basic research information now being generated in the addiction field to the practicing clinical addiction professional, but also translate critical information about new clinical developments back to the basic science researchers."

"On behalf of LWW, we're proud and excited to have been selected as ASAM's publishing partner," says Jeff McCaulley, President and CEO of Wolters Kluwer Health. "It's a unique opportunity to present the research, analysis, and debate that will shape the future of this essential specialty."

About ASAM
The American Society of Addiction Medicine ( www.asam.org) is the world's largest addiction medicine society dedicated to educating physicians and improving the treatment of individuals suffering from alcoholism and other addiction. ASAM's mission is to educate physicians and medical students, promote research and prevention, and enlighten and inform the medical community and the public about these issues.

About LWW
Lippincott Williams & Wilkins ( www.LWW.com) is a leading international publisher for physicians, nurses, specialized clinicians, and students. Nearly 275 periodicals and 1,500 books in more than 100 disciplines are published under the LWW brand, as well as content-based sites and online corporate and customer services. LWW is part of Wolters Kluwer Health, a leading provider of information for professionals and students in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Wolters Kluwer Health is a division of Wolters Kluwer, a leading global information services and publishing company with annual revenues (2005) of EUR 3.4 billion and approximately 18,400 employees worldwide. Visit  www.wolterskluwer.com.